Pilot Chemical expands into Latin America with Órgano Síntesis acquisition

By Simon Pitman

- Last updated on GMT

Getty Images
Getty Images

Related tags Chemicals Surfactant acquisition

US-based Pilot Chemicals has expanded into the Latin American markets with the acquisition of Órgano Síntesis, located in Toluca, Mexico.

The deal will give Pilot Chemicals a much improved footprint in the Mexico, Central American and South American markets for growth opportunities in the surfactants and antimicrobial business, much of which lays within the personal care arena.

According to Pillot Chemical executives, the deal is a part of the company’s strategy to increase growth and innovation, which will be achieved through the diversification of its international business and providing a platform for further growth in Latin America.

Expansion of R&D capabilities

The deal will also enable Pilot Chemical to expand its Good Manufacturing Practice testing and research and development capabilities, thanks to Órgano Síntesis existing facilities.

The deal will means that Órgano Síntesis, which trades under the acronym OSSA, will retain its name under the leadership of Pilot’s management.

Likewise, Frederico Soto, director general of OSSA’s group operations for the past 17 years, will remain in this position, reporting directly to Mike Clark, president and chief operation officer of Pilot Chemical.

The acquisition will also include OSSA’s workforce of nearly 100 people, as well as its production site at Toluca and its headquarters in Mexico City.

Enhancing growth and innovation

In reaching the acquisition agreement, the management of both companies believe that the resulting synergies will significantly both businesses, ultimately leading to further growth.

“Today marks an important milestone for Pilot​. OSSA greatly enhances our opportunities for growth and allows for further expansion into new technologies and manufacturing capabilities,” ​said Clark.

“It has an outstanding reputation in the marketplace, and together we are well positioned for the future.”

Related news

Related products

show more

Exosomes: Passing Trend or Transformative Reality?

Exosomes: Passing Trend or Transformative Reality?

Content provided by Naolys | 26-Mar-2024 | White Paper

Exosomes, microscopic vesicles naturally present in abundance within Plant Cells, have garnered significant attention within the scientific and cosmetic...

How Nutricosmetics Can Enhance Skin Beauty

How Nutricosmetics Can Enhance Skin Beauty

Content provided by Activ'Inside | 11-Dec-2023 | White Paper

In the ever-evolving realm of nutricosmetics, where inner wellness meets outer beauty, few natural ingredients have captured the spotlight quite like grapes.

Ultimate Antimicrobial Solution for BPC

Ultimate Antimicrobial Solution for BPC

Content provided by Acme-Hardesty Company | 11-Oct-2023 | White Paper

Sharomix™ EG10, a versatile broad-spectrum antimicrobial liquid blend for preserving personal care products, ensures safety at usage levels ranging from...

Acme-Hardesty Expands Product Line into Canada

Acme-Hardesty Expands Product Line into Canada

Content provided by Acme-Hardesty Company | 07-Jul-2023 | Product Brochure

Acme-Hardesty’s latest expansion into Canada includes Resplanta®, Botaneco®, and BYK from our partners Sharon Personal Care and Eckart Effect Pigments...

Related suppliers

Follow us


View more